Shionogi
Clinical trials sponsored by Shionogi, explained in plain language.
-
New drug tested for rare genetic brain disorder
Disease control OngoingThis study is testing whether an investigational drug called zatolmilast is safe and tolerable for people with Jordan's Syndrome, a rare genetic disorder that affects brain development. It involves about 30 participants aged 9 to 45 who have a confirmed diagnosis. The main goal i…
Phase: PHASE2 • Sponsor: Shionogi • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New drug aims to boost brain recovery after stroke
Disease control OngoingThis study is testing whether an investigational drug called redasemtide can help adults recover better after an acute ischemic stroke. It will compare the drug to a placebo in about 680 participants, including those who can and cannot receive standard clot-busting treatments. Th…
Phase: PHASE2 • Sponsor: Shionogi • Aim: Disease control
Last updated Mar 02, 2026 15:27 UTC